These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9377104)

  • 1. Immunostimulatory activities of mono- or diglycosylated alpha-galactosylceramides.
    Uchimura A; Shimizu T; Nakajima M; Ueno H; Motoki K; Fukushima H; Natori T; Koezuka Y
    Bioorg Med Chem; 1997 Jul; 5(7):1447-52. PubMed ID: 9377104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulatory activities of monoglycosylated alpha-D-pyranosylceramides.
    Uchimura A; Shimizu T; Morita M; Ueno H; Motoki K; Fukushima H; Natori T; Koezuka Y
    Bioorg Med Chem; 1997 Dec; 5(12):2245-9. PubMed ID: 9459022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory and antitumor activities of monoglycosylceramides having various sugar moieties.
    Motoki K; Morita M; Kobayashi E; Uchida T; Akimoto K; Fukushima H; Koezuka Y
    Biol Pharm Bull; 1995 Nov; 18(11):1487-91. PubMed ID: 8593464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3alpha- and 3beta-galactosylated alpha-galactosylceramides on the immune system.
    Sakai T; Morita M; Matsunaga N; Akimoto K; Yokoyama T; Iijima H; Koezuka Y
    Bioorg Med Chem Lett; 1999 Mar; 9(5):697-702. PubMed ID: 10201831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha- and beta-galactosylated C2-ceramides on the immune system.
    Sakai T; Ueno H; Natori T; Uchimura A; Motoki K; Koezuka Y
    J Med Chem; 1998 Feb; 41(4):650-2. PubMed ID: 9484513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship and conformational analysis of monoglycosylceramides on the syngeneic mixed leukocyte reaction.
    Iijima H; Kimura K; Sakai T; Uchimura A; Shimizu T; Ueno H; Natori T; Koezuka Y
    Bioorg Med Chem; 1998 Oct; 6(10):1905-10. PubMed ID: 9839020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.
    Sakai T; Naidenko OV; Iijima H; Kronenberg M; Koezuka Y
    J Med Chem; 1999 May; 42(10):1836-41. PubMed ID: 10346936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.
    Yamaguchi Y; Motoki K; Ueno H; Maeda K; Kobayashi E; Inoue H; Fukushima H; Koezuka Y
    Oncol Res; 1996; 8(10-11):399-407. PubMed ID: 9114432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
    Ko SY; Ko HJ; Chang WS; Park SH; Kweon MN; Kang CY
    J Immunol; 2005 Sep; 175(5):3309-17. PubMed ID: 16116223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
    Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
    J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRN7000, a novel immunomodulator, and its antitumor activities.
    Kobayashi E; Motoki K; Uchida T; Fukushima H; Koezuka Y
    Oncol Res; 1995; 7(10-11):529-34. PubMed ID: 8866665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
    Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
    Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
    Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T
    J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.
    Hossain MI; Hanashima S; Nomura T; Lethu S; Tsuchikawa H; Murata M; Kusaka H; Kita S; Maenaka K
    Bioorg Med Chem; 2016 Aug; 24(16):3687-95. PubMed ID: 27325450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-galactosylceramides on bone marrow cells in vitro and hematopoiesis in vivo.
    Motoki K; Morita M; Kobayashi E; Uchida T; Fukushima H; Koezuka Y
    Biol Pharm Bull; 1996 Jul; 19(7):952-5. PubMed ID: 8839968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated liver dendritic cells generate strong acquired immunity in alpha-galactosylceramide treatment.
    Sasakawa A; Tatsumi T; Takehara T; Yamaguchi S; Yamamoto M; Ohkawa K; Miyagi T; Hayashi N
    J Hepatol; 2009 Jun; 50(6):1155-62. PubMed ID: 19376606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95.
    Gaspar-Elsas MI; Queto T; Masid-de-Brito D; Vieira BM; de Luca B; Cunha FQ; Xavier-Elsas P
    Br J Pharmacol; 2015 Jul; 172(13):3313-25. PubMed ID: 25752588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.
    Parekh VV; Singh AK; Wilson MT; Olivares-Villagómez D; Bezbradica JS; Inazawa H; Ehara H; Sakai T; Serizawa I; Wu L; Wang CR; Joyce S; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3693-706. PubMed ID: 15356115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory potential of smokeless tobacco extract in in vitro cultures of murine lymphoid tissues.
    Goud SN; Zhang L; Kaplan AM
    Immunopharmacology; 1993; 25(2):95-105. PubMed ID: 8500987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NK-T cell activator (α-GalCer) accelerates immune and hematological reconstitution after murine allo-bone marrow transplantation].
    Liu JH; Zhou F; Dou LP; Liu YQ; Wang JG; Bai Y; Guo BY; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1542-7. PubMed ID: 21176367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.